Caution in the Use of Immunohistochemistry for Determination of Cell of Origin in Diffuse Large B-Cell Lymphoma

J Clin Oncol. 2015 Oct 1;33(28):3215-6. doi: 10.1200/JCO.2014.60.6731. Epub 2015 Aug 10.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Male
  • Thalidomide / analogs & derivatives*

Substances

  • Immunologic Factors
  • Thalidomide